NCT02422537

Brief Summary

During this project the effect of 3 different bran-based dietary platforms on the fermentation on a readily fermentable substrate will be investigated using stable isotope techniques.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable healthy

Timeline
Completed

Started Feb 2015

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2015

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 21, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2017

Completed
Last Updated

January 31, 2017

Status Verified

January 1, 2017

Enrollment Period

5 months

First QC Date

April 10, 2015

Last Update Submit

January 30, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Quantification of acetate, propionate and butyrate production in the colon after consumption of each bran-based dietary platform

    2 years

Secondary Outcomes (1)

  • Estimation of the site of fermentation of a readily fermentable carbohydrate in the presence of different bran-based dietary platforms

    2 years

Study Arms (4)

Unmodified wheat bran

ACTIVE COMPARATOR

One single dose om 20 g

Dietary Supplement: Unmodified wheat bran

Wheat bran with reduced particle size

ACTIVE COMPARATOR

One single dose of 20 g

Dietary Supplement: Wheat bran with reduced particle size

Destarched pericarp-enriched wheat bran

ACTIVE COMPARATOR

One single dose of 20 g

Dietary Supplement: Destarched pericarp-enriched wheat bran

No bran-based dietary platform

OTHER

No wheat bran fractions is administered

Dietary Supplement: No wheat bran fraction

Interventions

Unmodified wheat branDIETARY_SUPPLEMENT
Unmodified wheat bran
Wheat bran with reduced particle size
Destarched pericarp-enriched wheat bran
No wheat bran fractionDIETARY_SUPPLEMENT
No bran-based dietary platform

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy
  • Aged between 18 and 65 years
  • BMI between 18 and 27 kg/m²
  • Stable eating pattern (3 meals/day on at least 5 days/week)

You may not qualify if:

  • Use of antibiotics in the month preceding the study
  • Abdominal surgery (except from appendectomy)
  • Use of medication that affects the gastrointestinal tract during the last 2 weeks prior to the study including spasmolytics, anti-diarrhoea medication, anti-constipation medication
  • Use of pre- or probiotic supplements in the month preceding the study
  • Chronic gastrointestinal diseases, such as inflammatory bowel disease (Crohn's disease, ulcerative colitis), irritable bowel disease…
  • Pregnancy or lactation
  • Blood donation in the last 3 months
  • Abnormal Hb-level (Standard range between 14 and 18 g/dL for men and between 12 and 16 g/dL for women)
  • Participation in clinical studies involving radiation exposure in the past year

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

KU Leuven/ UZ Leuven

Leuven, Vlaams-Brabant, 3000, Belgium

Location

MeSH Terms

Interventions

Dietary Fiber

Intervention Hierarchy (Ancestors)

Dietary CarbohydratesCarbohydratesFoodDiet, Food, and NutritionPhysiological PhenomenaFood and Beverages

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Kristin Verbeke

Study Record Dates

First Submitted

April 10, 2015

First Posted

April 21, 2015

Study Start

February 1, 2015

Primary Completion

July 1, 2015

Study Completion

January 1, 2017

Last Updated

January 31, 2017

Record last verified: 2017-01

Locations